Anonymous User
Login / Registration

Gastroenterologie
a hepatologie

Gastroenterology and Hepatology

Gastroent Hepatol 2011; 65(3): 159-160.

Which non-steroidal anti-inflammatory drug should be used in patients with increased risk of gastrointestinal toxicity?

Martin Bortlík Orcid.org  1,2,3, Milan Lukáš Orcid.org  1

+ Affiliation

To read this article in full, please register for free on this website.

Benefits for subscribers

Benefits for logged users

Print

Credited self-teaching test

Start test

Most Read (last 6 month)

  1. Pancreatic cancer surveillance in high-risk individuals Position statement of professional societies
  2. Hepatobiliary complications in autosomal recessive polycystic kidney disease
  3. Practical clinical recommendations for perioperative care in bariatric surgery 2023: adaptation of ERAS (Enhanced Recovery After Surgery) recommendations with consensual voting of working group of Joint Section of Bariatric and Metabolic Surgery of Czech
  4. Benefits and limitations of physical activity in pediatric patients with inflammatory bowel diseases
  5. Evaluation of the association between red cell distribution width (anisocytosis) and degree of liver fibrosis in children with chronic liver diseases
  6. New perspectives in bariatric-metabolic treatment
  7. Pediatric gastroenterology and hepatology
  8. Pharmacological characteristics of subcutaneously administered monoclonal antibodies